Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Incompatible differences: view of an allogeneic pMHC-TCR complex.

× No keyword cloud information.

4 in total

1. A single amino-acid polymorphism in pocket A of HLA-A6602 alters the auxiliary anchors compared with HLA-A6601 ligands.

Authors: Christina Bade-Doeding; Holger-Andreas Elsner; Britta Eiz-Vesper; Axel Seltsam; Ute Holtkamp; Rainer Blasczyk
Journal: Immunogenetics Date: 2004-04-30 Impact factor: 2.846

2. Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain.

Authors: Michelle J Hickey; Colin C Malone; Kate L Erickson; Amy Lin; Horacio Soto; Edward T Ha; Shuichi Kamijima; Akihito Inagaki; Masamichi Takahashi; Yuki Kato; Noriyuki Kasahara; Barbara M Mueller; Carol A Kruse
Journal: Clin Cancer Res Date: 2013-06-18 Impact factor: 12.531

3. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA0101 and DRB10401): insight into TCR cross-restriction and alloreactivity.

Authors: Jens Hennecke; Don C Wiley
Journal: J Exp Med Date: 2002-03-04 Impact factor: 14.307

4. Development of a T-cell receptor mimic antibody targeting a novel Wilms tumor 1-derived peptide and analysis of its specificity.

Authors: Nobuyuki Kurosawa; Aki Midorikawa; Kenta Ida; Yuka Wakata Fudaba; Masaharu Isobe
Journal: Cancer Sci Date: 2020-08-26 Impact factor: 6.716

4 in total

Incompatible differences: view of an allogeneic pMHC-TCR complex.

1. A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands.

2. Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain.

3. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity.

4. Development of a T-cell receptor mimic antibody targeting a novel Wilms tumor 1-derived peptide and analysis of its specificity.

1. A single amino-acid polymorphism in pocket A of HLA-A6602 alters the auxiliary anchors compared with HLA-A6601 ligands.

3. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA0101 and DRB10401): insight into TCR cross-restriction and alloreactivity.